Human immunodeficiency virus and leprosy coinfection in Pune, India

Journal of Clinical Microbiology

Volumn 47, Issue 9, 2009, Pages 2998-2999

  Vinay, Kulkarni ^a   Smita, Joshi ^b   Nikhil, Gupte ^c   Neeta, Gokhale ^a  

^a PRAYAS   (India)

^b JEHANGIR HOSPITAL   (India)

^c B J MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COMORBIDITY; FEMALE; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INDIA; INFECTION RATE; LEPROSY; LUNG TUBERCULOSIS; MALE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; TUBERCULOSIS;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INDIA; LEPROSY; MALE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 69949088382     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00876-09     Document Type: Article

References (15)

1. Breton, G., X. Duval, C. Estellat, et al. 2004. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin. Infect. Dis. 39:1709-1712.
2. Couppié, P., S. Abel, H. Voinchet, et al. 2004. Immune reconstitution inflammatory syndromes associated with HIV and leprosy. Arch. Dermatol. 140:997-1000.
3. Government of India. March 2008. National Leprosy Elimination Programme report. Ministry of Health and Family Welfare, Government of India, New Delhi, India.
4. Jacob, J. T., and C. Franco-Paredes. 2008. The stigmatization of leprosy in India and its impact on future approaches to elimination and control. PLoS Negl. Trop. Dis. 2(1):ze113.
5. Lawn, S. D., C. Wood, and D. N. Lockwood. 2003. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person. Clin. Infect. Dis. 36:e5-e6.
6. Lortholary, O., A. Fontanet, N. Memain, et al. 2005. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 19:1043-1049.
7. National AIDS Control Organisation. 29 August 2007, posting date. Antiretroviral therapy guidelines for HIV infected adults and adolescents including post-exposure. National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, New Delhi, India. http://www. nacoonline.org/Quick-Links/Publication/.
8. Pignataro, P., A. S. Rocha, J. A. Nery, et al. 2004. Leprosy and AIDS: two cases of increasing inflammatory reactions at the start of highly active antiretroviral therapy. Eur. J. Clin. Microbiol. Infect. Dis. 23:408-411.
9. Shelburne, S. A., III, and R. J. Hamill. 2003. The immune reconstitution inflammatory syndrome. AIDS Rev. 5:67-79.
10. Talhari, C., P. R. L. Machado, L. C. Ferreira, and S. Talhari. 2007. Shifting of the clinical spectrum of leprosy in an HIV-positive patient: a manifestation of immune reconstitution inflammatory syndrome. Lepr. Rev. 78:151-154.
11. Trindade, M. A., N. Y. Valente, M. I. Manini, M. D. Takahashi, C. F. Anjos, G. Benard, and B. Naafs. 2006. Two patients coinfected with Mycobacterium leprae and human immunodeficiency virus type 1 and naive for antiretroviral therapy who exhibited type 1 leprosy reactions mimicking the immune reconstitution inflammatory syndrome. J. Clin. Microbiol. 44:4616-4618.
12. UNAIDS. December 2007. AIDS epidemic update. UNAIDS. http://data.unaids. org/pub/EPISlides/2007/071119-epi-pressrelease-en.pdf. Accessed 13 March 2008.
13. Visco-Comandini, U., B. Longo, T. Cuzzi, M. G. Paglia, and G. Antonucci. 2004. Tuberculoid leprosy in a patient with AIDS: a manifestation of immune restoration syndrome. Scand. J. Infect. Dis. 36:881-883.
14. Weekly Epidemiological Record. 2007. Global leprosy situation. Wkly. Epidemiol. Rec. 82:225-232.
15. World Health Organization. 22 December 2006, last update. Leprosy tools and guidelines. World Health Organization, Geneva, Switzerland. http://www.searo.who.int/EN/Section10/Section20/Section57-9882.htm.